Trial Profile
TREATMENT SATISFACTION COMPARISON IN RHEUMATOID ARTHRITIS PATIENTS BETWEEN TOFACITINIB CITRATE AND ADALIMUMAB, EACH USED IN RHEUMATOID ARTHRITIS TREATMENT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 May 2020 Status changed from recruiting to completed.
- 03 Feb 2020 Planned End Date changed from 31 Dec 2019 to 31 Mar 2020.
- 03 Feb 2020 Planned primary completion date changed from 31 Dec 2019 to 31 Mar 2020.